Financials

News Discussions Technicals Seasonals

OPTI fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Optibiotix Health Plc engages in the research and development of compounds that modify the human microbiome. Its products include SlimBiome, LPLDL, CholBiome, SweetBiotix, LPGOS, and WellBiome. The company was founded by Stephen Patrick O'Hara on June 19, 2006, and is headquartered in Heslington, the United Kingdom.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

OPTI does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company